New York State Common Retirement Fund 89bio, Inc. Transaction History

New York State Common Retirement Fund

$74.9 Billion
Q3 2025

A detailed history of New York State Common Retirement Fund transactions in 89bio, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 39,467 shares of ETNB stock, worth $585,690. This represents 0.0% of its overall portfolio holdings.

Number of Shares

39,467

Previous 39,467 -0.0%

Holding current value

$585,690

Previous $387,000 49.61%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Oct 08, 2025	BUY	$4.83 - $10.57 $65,205 - $142,695	13,500 Added 51.99%	39,467 $387,000
Q2 2025 Aug 13, 2025	BUY	$4.83 - $10.57 $65,205 - $142,695	13,500 Added 51.99%	39,467 $388,000
Q1 2025 Oct 08, 2025	BUY	$6.18 - $11.66 $59,328 - $111,936	9,600 Added 58.65%	25,967 $188,000
Q1 2025 May 01, 2025	BUY	$6.18 - $11.66 $59,328 - $111,936	9,600 Added 58.65%	25,967 $189,000
Q4 2024 Oct 08, 2025	BUY	$7.03 - $10.05 $22,496 - $32,160	3,200 Added 24.3%	16,367 $125,000

Q4 2024 Jan 31, 2025	BUY	$7.03 - $10.05 $22,496 - $32,160	3,200 Added 24.3%	16,367 $128,000
Q3 2024 Oct 08, 2025	SELL	$7.36 - $9.66 $193,568 - $254,058	-26,300 Reduced 66.64%	13,167 $97,000
Q3 2024 Oct 28, 2024	SELL	$7.36 - $9.66 $95,680 - $125,580	-13,000 Reduced 49.68%	13,167 $97,000
Q2 2024 Oct 08, 2025	SELL	$7.31 - $10.9 $97,223 - $144,970	-13,300 Reduced 33.7%	26,167 $209,000
Q2 2024 Jul 31, 2024	SELL	$7.31 - $10.9 $20,533 - $30,618	-2,809 Reduced 9.69%	26,167 $210,000
Q1 2024 Oct 08, 2025	SELL	$8.13 - $13.77 $85,291 - $144,461	-10,491 Reduced 26.58%	28,976 $337,000
Q1 2024 May 07, 2024	BUY	$8.13 - $13.77 $23,861 - $40,414	2,935 Added 11.27%	28,976 $337,000
Q4 2023 Oct 08, 2025	SELL	$6.66 - $16.03 $89,417 - $215,218	-13,426 Reduced 34.02%	26,041 $290,000
Q4 2023 Feb 01, 2024	BUY	$6.66 - $16.03 $7,925 - $19,075	1,190 Added 4.79%	26,041 $291,000
Q3 2023 Oct 08, 2025	SELL	$15.06 - $19.41 $220,116 - $283,696	-14,616 Reduced 37.03%	24,851 $383,000
Q3 2023 Nov 07, 2023	BUY	$15.06 - $19.41 $9,804 - $12,635	651 Added 2.69%	24,851 $384,000
Q2 2023 Oct 08, 2025	SELL	$14.15 - $22.03 $216,028 - $336,332	-15,267 Reduced 38.68%	24,200 $458,000
Q2 2023 Aug 07, 2023	BUY	$14.15 - $22.03 $342,430 - $533,126	24,200 New	24,200 $459,000
Q2 2022 Aug 04, 2022	SELL	$2.09 - $4.02 $16,929 - $32,561	-8,100 Reduced 98.95%	86 $0
Q1 2022 May 05, 2022	BUY	$3.45 - $14.99 $17 - $74	5 Added 0.06%	8,186 $31,000
Q4 2021 Feb 02, 2022	SELL	$11.15 - $19.66 $167 - $294	-15 Reduced 0.18%	8,181 $107,000
Q3 2021 Nov 02, 2021	BUY	$14.91 - $21.31 $447 - $639	30 Added 0.37%	8,196 $161,000
Q2 2021 Aug 02, 2021	BUY	$17.42 - $28.0 $1,149 - $1,848	66 Added 0.81%	8,166 $153,000
Q4 2020 Feb 08, 2021	BUY	$23.16 - $28.08 $97,272 - $117,936	4,200 Added 107.69%	8,100 $197,000
Q4 2019 Feb 05, 2020	BUY	$19.75 - $33.44 $77,025 - $130,415	3,900 New	3,900 $103,000

Others Institutions Holding ETNB

# of Institutions

228

Shares Held

153M

Call Options Held

774K

Put Options Held

6.48M

View Full List

About 89bio, Inc.

Ticker ETNB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,484,500
Market Cap $690M
Description
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...

More about ETNB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account

New York State Common Retirement Fund 89bio, Inc. Transaction History